Journal of Clinical Endocrinology & Metabolism, Vol 54, 980-985, Copyright © 1982 by Endocrine Society

ARTICLES

Bombesin: action on gut hormones and calcium in man

MA Ghatei, RT Jung, JC Stevenson, CJ Hillyard, TE Adrian, YC Lee, ND Christofides, DL Sarson, K Mashiter, I MacIntyre and SR Bloom

Bombesin, a peptide with widespread biological actions, has been demonstrated in human tissues by immunological methods. To investigate its effect in man, synthetic bombesin was infused at low doses in six male volunteers. Bombesin at 2.4 pmol kg-1 min-1 produced significant rises in plasma insulin, glucagon, pancreatic polypeptide, gastrin, cholecystokinin, motilin, glucose-dependent insulinotropic polypeptide, neurotensin, enteroglucagon, vasoactive intestinal polypeptide, and serum calcium. In contrast, bombesin caused a profound fall in parathyroid hormone levels and reduced plasma glucose concentrations. A late rise in plasma calcitonin was also observed. Bombesin had no significant effect on the pituitary hormones, TSH, GH, PRL, or cortisol. No hormonal changes or alterations in calcium were noted during saline infusions. Bombesin has a marked stimulatory effect on gastrointestinal hormones, which is unique and opposite to the effect of somatostatin, a potent inhibitor of gut hormone release. Bombesin also influences calcium-regulating hormones, either directly or through its action on gut hormones. The bombesin concentrations achieved with the dosages used were low enough to indicate a possible physiological role for the endogenous peptide.

This article has been cited by other articles:

				R. T. Jensen, J. F. Battey, E. R. Spindel, and R. V. Benya International Union of Pharmacology. LXVIII. Mammalian Bombesin Receptors: Nomenclature, Distribution, Pharmacology, Signaling, and Functions in Normal and Disease States Pharmacol. Rev., March 1, 2008; 60(1): 1 - 42. [Abstract] [Full Text] [PDF]

				R. E. Carroll, K. A. Matkowskyj, S. Chakrabarti, T. J. McDonald, and R. V. Benya Aberrant expression of gastrin-releasing peptide and its receptor by well-differentiated colon cancers in humans Am J Physiol Gastrointest Liver Physiol, March 1, 1999; 276(3): G655 - G665. [Abstract] [Full Text] [PDF]

				R. R. Ryan, H. C. Weber, W. Hou, E. Sainz, S. A. Mantey, J. F. Battey, D. H. Coy, and R. T. Jensen Ability of Various Bombesin Receptor Agonists and Antagonists to Alter Intracellular Signaling of the Human Orphan Receptor BRS-3 J. Biol. Chem., May 29, 1998; 273(22): 13613 - 13624. [Abstract] [Full Text] [PDF]

				R. V. Benya, T. Kusui, J. F. Battey, and R. T. Jensen Chronic Desensitization and Down-regulation of the Gastrin-releasing Peptide Receptor Are Mediated by a Protein Kinase C-dependent Mechanism J. Biol. Chem., February 17, 1995; 270(7): 3346 - 3352. [Abstract] [Full Text] [PDF]

				K. Tokita, S. J. Hocart, T. Katsuno, S. A. Mantey, D. H. Coy, and R. T. Jensen Tyrosine 220 in the 5th Transmembrane Domain of the Neuromedin B Receptor Is Critical for the High Selectivity of the Peptoid Antagonist PD168368 J. Biol. Chem., January 5, 2001; 276(1): 495 - 504. [Abstract] [Full Text] [PDF]